We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genzyme Warned for Fabrazyme Computerized Production Problems
Genzyme Warned for Fabrazyme Computerized Production Problems
March 13, 2009
Genzyme did not update its computerized manufacturing system for Fabrazyme, a treatment for Fabry disease, and ran an aseptic filling line at an unvalidated line speed, according to an FDA warning letter.